» Articles » PMID: 26841913

Renal Unit Practitioners' Knowledge, Attitudes and Practice Regarding the Safety of Unfractionated Heparin for Chronic Haemodialysis

Overview
Journal Curationis
Specialty Nursing
Date 2016 Feb 5
PMID 26841913
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic haemodialysis for adult patients with end-stage kidney failure requires a patent extracorporeal circuit, maintained by anticoagulants such as unfractionated heparin (UFH). Incorrect administration of UFH has safety implications for patients.

Objectives: Firstly, to describe renal practitioners' self-reported knowledge, attitudes and practice (KAP) regarding the safe use of UFH and its effects; secondly, to determine an association between KAP and selected independent variables.

Method: A cross-sectional descriptive survey by self-administered questionnaire and non-probability convenience sampling was conducted in two tertiary hospital dialysis units and five private dialysis units in 2013.

Results: The mean age of 74/77 respondents (96.1%), was 41.1 years. Most (41/77, 53.2%) had 0-5 years of renal experience. The odds of enrolled nurses having poorer knowledge of UFH than registered nurses were 18.7 times higher at a 95% Confidence Interval (CI) (1.9-187.4) and statistically significant (P = 0.013). The odds of delivering poor practice having ≤ five years of experience and no in-service education were 4.6 times higher at a 95% CI (1.4-15.6), than for respondents who had ≥ six years of experience (P = 0.014) and 4.3 times higher (95% CI 1.1-16.5) than for respondents who received in-service education (P = 0.032), the difference reaching statistical significance in both cases.

Conclusion: Results suggest that the category of the professional influences knowledge and, thus, safe use of UFH, and that there is a direct relationship between years of experience and quality of haemodialysis practice and between having in-service education and quality of practice.

Citing Articles

Knowledge, attitude, and practice of nephrologists on the decision for renal replacement therapy.

Hu X, Yang M, Li X, Chen Y, Ouyang S, Li L BMC Public Health. 2023; 23(1):654.

PMID: 37020206 PMC: 10077733. DOI: 10.1186/s12889-023-15530-0.

References
1.
Pittard J . Heparin therapy in routine hemodialysis. Nephrol News Issues. 2002; 15(5):73-5. View

2.
Brunet P, Simon N, Opris A, Faure V, Lorec-Penet A, Portugal H . Pharmacodynamics of unfractionated heparin during and after a hemodialysis session. Am J Kidney Dis. 2008; 51(5):789-95. DOI: 10.1053/j.ajkd.2007.12.040. View

3.
Marx R, Menezes A, Horovitz L, Jones E, Warren R . A comparison of two time intervals for test-retest reliability of health status instruments. J Clin Epidemiol. 2003; 56(8):730-5. DOI: 10.1016/s0895-4356(03)00084-2. View

4.
. Section V. Chronic intermittent haemodialysis and prevention of clotting in the extracorporal system. Nephrol Dial Transplant. 2002; 17 Suppl 7:63-71. DOI: 10.1093/ndt/17.suppl_7.63. View

5.
Rousson V, Gasser T, Seifert B . Assessing intrarater, interrater and test-retest reliability of continuous measurements. Stat Med. 2002; 21(22):3431-46. DOI: 10.1002/sim.1253. View